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Abstract: The replacement of disease hepatocytes and the stimulation of endogenous or 
exogenous regeneration by human mesenchymal stem cells (MSCs) are promising 
candidates for liver-directed cell therapy. In this study, we isolated MSCs from adult bone 
marrow by plastic adhesion and induced differentiation with a liver differentiation 
protocol. Western blot analyses were used to assess the expression of liver-specific 
markers. Next, MSC-specific proteins were analyzed with two-dimensional (2D) gel 
electrophoresis and peptide mass fingerprinting matrix-assisted laser desorption/ionization 
(MALDI)-time of flight (TOF)-mass spectrometry (MS). To confirm the results from the 
proteomic study, semi-quantitative reverse transcription-polymerase chain reaction   
(RT-PCR) analyses were performed. We demonstrated that MSCs treated with the liver 
differentiation protocol expressed significantly more albumin, CK19 and CK20, than did 
undifferentiated cells. In addition the results of proteomic study demonstrated increases 
expression of FEM1B, PSMC2 and disulfide-isomerase A3 in MSCs treated with the liver 
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differentiation protocol. These results from proteomic profiling will not only provide 
insight into the global responses of MSCs to hepatocyte differentiation, but will also lead 
to in-depth studies on the mechanisms of proteomic changes in MSCs. 
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1. Introduction 
Most liver diseases lead to hepatocyte dysfunction, with the possibility of eventual organ failure. 
Previous studies demonstrated the plasticity of MSCs to differentiate into other cells of the 
mesodermal lineage, including pancreatic cells and hepatocyte-like cells in vitro [1–3]. Therefore, the 
replacement of disease hepatocytes and the stimulation of endogenous or exogenous regeneration by 
human mesenchymal stem cells (MSCs) are promising candidates for liver-directed cell therapy. 
Previous studies have demonstrated that MSCs possess an extensive potential to differentiate into 
hepatocyte-like cells by using cytokines and growth factors that have a potent effect on hepatic growth 
and differentiation in vitro [4]. However, the effect of this protocol on MSCs has not been investigated 
comprehensively, and should be addressed before clinical use.  
With conventional molecular biological assays, the identification of protein expression can be 
performed on a limited number of proteins. Proteomics offer a systematic study of the quantitative and 
qualitative mapping of the entire proteome [5]. In this study, we induced MSCs using a liver 
differentiation protocol and two-dimensional (2D) electrophoresis to separate the proteins by 
isoelectric focusing (IEF) and SDS-PAGE. Proteins separated by 2D electrophoresis were then 
digested and analyzed by mass spectrometry (MS). We demonstrated that increased expression of the 
mesenchymal marker vimentin and FEM1B, PSMC2 and disulfide-isomerase A3 were found in MSCs 
treated with the liver differentiation protocol.  
2. Results  
2.1. Induction of MSCs Using the Liver Differentiation Protocol  
As revealed by morphological studies, MSCs cultured in the liver differentiation media for four 
weeks adopted polygonal cell morphology. The nucleus and cytoplasm appeared granulated (Figure 1) 
and were still viable after 60 days. To verify whether these differentiated cells had the characteristic 
expression of hepatic phenotypic markers, protein from undifferentiated and differentiated cells was 
extracted. Western blot analyses demonstrated that differentiated MSCs expressed significantly more 
albumin, CK19 and CK20 than did undifferentiated cells (control) (Figure 2A). In addition, the 
expression of albumin was also found in differentiated MSCs after 60 days (Figure 2B). The presence 
of glycogen in the cytoplasm of differentiated MSCs was demonstrated by PAS staining (Figure 3A). 
Additionally, MSCs themselves did not produce urea. When MSCs were cultured for three weeks in 
the liver differentiation media, urea was secreted in the supernatant (Figure 3B).  Int. J. Mol. Sci. 2010, 11                 
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2.2. Protein Expression Changed in Differentiated MSCs 
We used a proteomic approach to profile the protein expression in MSCs treated with the liver 
differentiation protocol. The proteins in the cell lysates were separated by two-dimensional 
electrophoresis followed by Coomassie staining. A representative two-dimensional gel image of 
protein lysates from MSCs with and without being cultured in the liver differentiation protocol is 
shown in Figure 4A. These protein spots, encompassing a wide range of molecular weights, pI values, 
and abundance were resolved and identified with high confidence (95%). We demonstrated that 
increases in vimentin, FEM1B, PSMC2 and disulfide-isomerase A3 expression were found in MSCs 
treated with the liver differentiation protocol. 
To confirm the results of the proteomic studies, total RNA from undifferentiated and differentiated 
MSCs cells and normal liver specimens was isolated, and the mRNA levels of the genes of interest were 
examined by RT-PCR. Expression of FEM1B, PSMC2 and disulfide-isomerase A3, were significantly 
increased in these differentiated cells when compared to the undifferentiated cells (Figure 4B).  
To study whether or not the expression of FEM1B, PSMC2 and disulfide-isomerase A3 was 
specific only for MSCs treated with the liver differentiation protocol, we measured the expression of 
these genes in the MSCs treated with fat differentiation protocol. These MSCs treated with fat 
differentiation protocol were derived from our previous study [6]. These cells demonstrated many  
fat globules in their cytoplasm (Figure 5A). The results demonstrated that the expression of   
disulfide-isomerase A3 was up-regulated in MSCs treated with fat differentiation protocol. However, 
there is no change in the expression of FEM1B and PSMC2 in MSCs treated with fat differentiation 
protocol when compared to the undifferentiated cells (Figure 5B). 
3. Discussion  
Several studies have demonstrated that MSCs easily differentiate into mesenchymal tissue lineages, 
including bone, cartilage, fat, tendon, muscle, and bone marrow. Moreover, they also differentiate into 
cells of ectodermal origin, such as neurons [7]. Our findings demonstrate that treating MSCs with the 
liver differentiation protocol induces a profound change in gene and protein expression that resembled 
cells derived from hepatocytes from the endoderm. These findings were reproducible in cells from six 
donors of both sexes.  
The present study demonstrates that MSCs treated with the liver differentiation protocol expressed 
proteins that are compatible with liver cells, including albumin, CK19 and CK20. This finding was 
further supported by the positive results of PAS staining and urea production. Using two-dimensional 
gel electrophoresis (2-DE) and mass spectrometry (MS), we demonstrated for the first time that 
PSMC2, FEM1B and disulfide-isomerase A3 were highly expressed in MSCs treated with the liver 
differentiation protocol. We also found that the expression of PSMC2 and FEM1B was demonstrated 
in MSCs treated with the liver differentiation protocol but not in MSCs treated with the fat 
differentiation protocol. PSMC2 is the 26S proteasome. that is composed of two complexes, a 20S core 
and a 19S regulator. Functionally, the PSMC2 gene has been proposed to participate in protein 
catabolic processes or proteolysis [8]. Previous studies demonstrated that this PSMC2 gene can be 
detected at high levels in injured skeletal muscle [9], and liver [8]. This finding suggested that the  Int. J. Mol. Sci. 2010, 11                 
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up-regulation of PSMC2 was associated with an increase of protein catabolic processes in MSCs 
treated with the liver differentiation protocol.  
PDIA3 (protein disulfide isomerase A3) is a member of the endoplasmic reticulum stress signaling 
pathway, and its expression level increases in response to cellular stress due to its function as a 
chaperone. It interacts with the lectin chaperones. calreticulin and calnexin. to modulate the folding of 
newly synthesized glycoproteins [10]. PDIA3 was also up-regulated in MSCs treated with the liver 
differentiation protocol. Previous studies demonstrated that PDIA3 was strongly expressed in many 
kinds of cells, including pancreatic, placental, lung and liver cells [11]. Recently published data 
connected PDIA3 to apoptosis and demonstrated an anti-apoptotic effect of PDIA3 in the melanoma 
cell line A375 after induction of ER stress [12]. In this study, we also demonstrated that PDIA3 is up-
regulated in MSCs treated with fat differentiation protocol. Therefore, we hypothesize that the 
observed increase of PDIA3 in this study is most likely due to elevated cellular stress.  
A previous study has demonstrated that fem-1 is an ankyrin repeat protein involved in the regulatory 
pathway controlling cell fate decisions during sex determination in the nematode [13]. The Fem1 gene 
family that encodes fem-1 homologs has been characterized and consists of at least three members in 
the mouse, designated Fem1a,  Fem1b, and Fem1c; these Fem1  members have highly conserved 
homologs in humans, designated FEM1A, FEM1B, and FEM1C, respectively [14]. The mammalian 
Fem1 genes are expressed in tissues involved in glucose physiology, including pancreatic tissue and 
skeletal muscle [13]. In this study, we found that human liver tissues and MSCs treated with the liver 
differentiation protocol expressed FEM1B. We suggested that the up-regulation of FEM1B may be 
involved in the metabolism of glucose in MSCs treated with the liver differentiation protocol. The 
exact role of FEM1B in human liver cell function and differentiation should be further- investigated.  
Table 1. Primer Sequences for RT-PCR. 
Primer Forward  Reverse  Length 
FEM1B ACATTACCGGGTGCAGACTC  TTGTTGGCAATGCTGATGTT 255  bp 
PSMC2 GGCAGATCAAGCAAGTTGAAG  TATTTTGGGTCCTCCGAATC 205  bp 
PDIA3 CGAGCGCAAGCAGCGGGTTA TGTCCACACCAGGGGGCGAA  271  bp 
GAPDH GAAGGTGAAGGTCGGAG GAAGATGGTGATGGGATTTC 226  bp 
Figure 1. The MSCs cells culture under a phase contrast microscope at 20 × magnification: 
(A) Control; (B) cells were treated with liver differentiation protocol for 28 days.  
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Figure 2. (A) The expression of CK-19 and CK-20 in MSCs cells was determined by 
western blotting. Cells were treated with liver differentiation protocol or control vehicle 
(DMSO) for 21 days.  tubulin was used as a loading control. The relative levels of CK-19 
and CK-20 protein were assessed by scanning densitometry of western blots. Data 
represent the mean ± SD of three independent experiments (significant as compared with 
control, * p = 0.04, ** p < 0.001); (B) The expression of albumin in MSCs cells treated 
with liver differentiation protocol for 0–60 days was determined by western blotting.   
 tubulin was used as a loading control. The relative levels of albumin protein were 
assessed by scanning densitometry of western blots. Data represent the mean ± SD of three 
independent experiments (significant as compared with control, * p = 0.002, ** p < 0.001).  
 
Figure 3. ( A) Detection of glycogen in the cytoplasm of MSCs treated with liver 
differentiation protocol was demonstrated by PAS staining. PAS positive substances stain 
pink in the cytoplasm of the cells; (B) The urea production was determined. Cells were 
treated with liver differentiation protocol or control vehicle (DMSO) for 21 days. Studies 
were done in triplicate and repeated twice. Data represent the mean  ±  SD of three 
independent experiments (significant as compared with control, * p < 0.001). 
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Figure 4. ( A) Proteome map of protein extraction from MSC control and treatment. 
Identification of proteins were performed by 2D gel electrophoresis follow by   
MALDI-TOF-MS. Isoelectric focusing were performed with 50 g total proteins from 
MSC using 3–10 pH-strips, 18 cm. SDS-PAGE were performed on 12.5% gels and stained 
with Coomassie blue G-250; (B) Total RNA was isolated from MSCs cells treated with or 
without liver differentiation protocol and liver specimens. Expression of FEM1B, PSMC2 
and disulfide-isomerase A3 mRNA levels was evaluated using RT-PCR. The results, based 
on the ratio of these mRNA amplification to that of GAPDH, are presented as the fold 
increase relative to the mRNA levels from liver specimens. The results are expressed as the 
mean ± SD of three separate experiments (* p < 0.001, ** p = 0.01 versus the control MSC). 
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Figure 5. (A) The fat globules were demonstrated in the cytoplasm of MSCs cells treated 
with fat differentiation protocol; (B) Total RNA was isolated from MSCs cells treated  
with or without fat differentiation protocol. Expression of FEM1B, PSMC2 and   
disulfide-isomerase A3, mRNA levels was evaluated using RT-PCR. The results, based on 
the ratio of these mRNA amplification to that of GAPDH, are presented as the fold 
increase relative to the mRNA levels from MSC control. The results are expressed as the 
mean ± SD of three separate experiments (* p < 0.001 versus the control MSC). 
4. Experimental Section  
Dulbecco’s Modified Eagle’s medium (DMEM-low glucose) was purchased from Gibco   
(Paisley, U.K.). Phosphate-buffered saline (PBS) and dexamethasone were obtained from Merck 
Pharma (Mollet del Vallés, Spain). Trypsin-EDTA and newborn calf serum were obtained from 
Biochrom AG (Berlin, Germany). ITS and premix were purchased from BD Biosciences (Madrid, 
Spain). Basic fibroblast growth factor (bFGF) was purchased from Invitrogen (Barcelona, Spain). 
Hepatocyte growth factor (HGF), epidermal growth factor (EGF) and nicotinamide were from   
Sigma-Aldrich (Madrid, Spain). Oncostatin M (OMS) was purchased from PeproTech EC (London, 
U.K.). Polyclonal rabbit anti-human albumin, alphafetoprotein, polyclonal goat anti-mouse HRP and 
polyclonal goat anti-rabbit HRP were purchased from DakoCytomation (Barcelona, Spain). 
4.1. Isolation and Culture of MSCs 
MSCs were selected from 10 mL aspirates from the iliac crest of normal adult donors after informed 
consent was given. Cells were plated at a density of 1,000,000 cells per 25 cm
2 flask in 5 mL of 
DMEM-low glucose supplemented with 100 μg/mL penicillin, 100 μg/mL streptomycin (Invitrogen),  
2 mmol/L L-glutamine (Invitrogen), and 10% fetal calf serum (Invitrogen), incubated at 37 °C in a 
humidified atmosphere containing 5% CO2. After 72 hours, the nonadherent cells were discarded, and Int. J. Mol. Sci. 2010, 11                 
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adherent cells were washed gently with medium and cultured for approximately 21 days. Fresh 
complete medium was replaced twice a week.  
4.2. Liver Differentiation Protocol  
MSCs cultured at 85% confluency were used for the differentiation assays. The cells were cultured 
in DMEM supplemented with 20 ng/mL EGF and 10 ng/mL bFGF. Then a 2 step differentiation 
protocol was performed. First, the cells were cultured in step-1 differentiation medium consisting of 
DMEM supplemented with 20 ng/mL HGF, 10 ng/mL bFGF and 4.9 mmol/L nicotinamide, for 7 d, 
followed by culture in step 2 differentiation medium that consisted of DMEM supplemented with  
20  ng/mL  OMS, 1 mmol/L dexamethasone, and 10 mL/mL ITS  +  premix (final concentration:   
100  mmol/L insulin, 6.25 mg/mL transferrin, 3.6 mmol/L selenious acid, 1.25 mg/mL BSA and 
190 mmol/L linoleic acid) to achieve cell maturation (up to Day 21).  
4.3. Western Blot Analyses 
Control MSCs and MSCs treated with the liver differentiation protocol were collected, washed with 
PBS and lysed in lysis buffer. Western blot analyses were performed as previously described [16]. The 
blots were first probed with antibodies against albumin, cytokeratin 19 and cytokeratin 20 and then 
reprobed with antibodies against tubulin. Bound antibodies were detected using chemiluminescence.  
4.4. Periodic Acid-Schiff  
Periodic acid-Schiff (PAS) staining was performed to detect glycogen granules in the hepatocytic 
cytoplasm, according to the manufacturer’s instructions (Sigma). The cells were fixed in   
formalin-ethanol fixative solution for 1 minute at room temperature. Then the slides were immersed in 
periodic acid solution for 5 minutes and Schiff’s reagent for 15 minutes. Counterstain slides in 
Hematoxylin solution and examined under the light microscope.  
4.5. Urea Production Assay 
Urea concentrations were determined by colorimetric assay (QuantiChromTM Urea Assay Kit) per 
manufacturer's instructions. Briefly, 20 μL of standard, culture supernatant or media was added to a 
cuvette; then 1 mL of working reagent was added and incubated for 20 minutes before the absorbance 
reading at the optical density at 520 nm was examined. HepG2 (human hepatocellular carcinoma cell 
line) grown in monolayer were used as a positive controls and fresh culture medium used as 
negative control.  
4.6. Two-Dimensional Gel Electrophoresis (2D-GE), Gel Scanning and Image Analysis 
For the first dimension, the protein samples were combined with the rehydration buffer (7 M urea, 
2 M thiourea, 4% CHAPS, 60 mM DTT, 1% Pharmalyte or IPG Buffer pH 3–10) to a total volume of 
340 mL. An isoelectric focusing gel was performed using an 18 cm Immobilime DryStrip gel with a 
linear pH 3–10 and an Ettan IPGphor 3 Manifolds system (GE Healthcare, U.S.) for a total of 32 kVh 
at 20 C. Following IEF, each strip gel was equilibrated with equilibration buffer. The strip gels were Int. J. Mol. Sci. 2010, 11                 
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loaded and run in 12.5% acrylamide gels using the Ettan DALTsix Electrophoresis System. The run 
was stopped once the bromophenol blue dye front had run off the bottom of the gels. The gels were 
stained with Colloidal Coomassie staining, and the proteins were visualized using ImageScanner. The 
gel images were analyzed using a differential protein expression profile by ImageMaster 2D Platinum 
software (GE Healthcare). 
4.7. Tryptic in-Gel Digestion of 2-DE Spots and MALDI-TOF MS 
Protein spots were picked and transferred into a 96-well microplate and subjected to in-gel 
digestion, which was performed using an Ettan Spot Handling workstation (GE Healthcare). Peptide 
mass fingerprinting (PMF) was performed using an Autoflex MALDI-TOF mass spectrometer (Bruker 
Daltonics, Germany). The matrix solution, a-cyano-4-hydroxycinnamic acid (Bruker), was prepared by 
dissolving one part acetonitrile with two parts 0.1% trifluoroacetic acid in water. The digested peptide 
was then mixed with matrix solution, and the mixture was spotted onto a stainless-steel target and left 
to dry at room temperature. The PMFs were recorded by reflectron mode. The resulted PMFs were 
visualized by flexAnalysis software version 2.0 (Bruker Daltonics). 
4.8. Database Search for Protein Identification 
PMFs were used for protein identification from tryptic fragment sizes using the MASCOT search 
engine (www.matrixscience.com) based on the entire NCBInr protein database (Homo sapiens) using 
peptide monoisotopic peaks. 
4.9. RNA Extraction and RT-PCR 
Total RNA was extracted from undifferentiated (used as control) and differentiated cells using 
Trizol reagent. Detection of mRNA transcription of FEM1B, PSMC2, disulfide-isomerase A3 and 
GAPDH were performed by RT-PCR. The sequences of both the forward and reverse primers and the 
expected sizes of the PCR-amplified DNA are listed in Table 1. Amplification and detection was 
performed in a BIO-RAD iCycler iQ system (Bio-Rad, Hercules, CA). The reaction conditions were 
reverse transcription at 60 °C for 10 min, followed by the amplification by initial denaturation at 95 °C 
for 30 s and 40 cycles of denaturation at 95 °C for 30 s, annealing at 60 °C for 30 s, and extension at 
72 °C for 60 s, respectively. The PCR products were detected with 1.5% agarose gel electrophoresis. 
4.10. Statistical Analysis  
The experiments were all performed in triplicate, and each result is reported as the mean plus or 
minus the SD. The data between the two groups were compared using the Student’s t-test. A p-value of 
less than 0.05 was considered as statistically significant. 
5. Conclusions 
In summary, this study identified a set of proteins that were up-regulated in MSCs treated with a 
liver differentiation protocol. These proteins were involved in important functional processes Int. J. Mol. Sci. 2010, 11                 
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important for such cellular functions as apoptosis, protein folding, and metabolism. We believe that 
these observations shed new light on the processes of liver differentiation from MSCs. 
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